missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ LRRK2 [G2019S] Recombinant Protein
Mutations in the leucine-rich repeat kinase 2 (LRRK2) gene, which codes for a multidomain protein kinase, are considered the most common genetic cause of late-onset autosomal-dominant Parkinson's disease.
4000.00 NOK - 91100.00 NOK
Specifications
Accession Number | NP_940980.3 |
---|---|
Gene Alias | AURA17, DARDARIN, PARK8, RIPK7, ROCO2 |
KinaseFamily | LRRK Kinase Family |
Species | Human |
Protein Tag | DYKDDDDK |
Product Code | Brand | Quantity | Price | Quantity & Availability | |||||
---|---|---|---|---|---|---|---|---|---|
Product Code | Brand | Quantity | Price | Quantity & Availability | |||||
15458363
|
Invitrogen™
A15201 |
100μg |
19150.00 NOK
100µg |
Estimated Shipment: 16-05-2024 Log in to see stock. |
Please sign in to purchase this item. Need a web account? Register with us today! | ||||
15310861
|
Invitrogen™
A15200 |
10 μg |
4000.00 NOK
10µg |
Estimated Shipment: 15-05-2024 Log in to see stock. |
Please sign in to purchase this item. Need a web account? Register with us today! | ||||
15468363
|
Invitrogen™
A15202 |
1mg |
91100.00 NOK
1mg |
Estimated Shipment: 16-05-2024 Log in to see stock. |
Please sign in to purchase this item. Need a web account? Register with us today! | ||||
Description
This full-length, purified and active LRRK2 G2019S mutant protein may be useful in research to better understand the most common Parkinson's disease-relevant mutant, as well as to explore the mechanisms underlying the disease.
- Increase disease relevance by interrogating a purified and active full-length LRRK2 protein
- Uncover novel compounds or hits specific to the full-length form
- Advance Parkinson 's research using the full-length protein and validated assays
Specifications
NP_940980.3 | |
LRRK Kinase Family | |
DYKDDDDK |
AURA17, DARDARIN, PARK8, RIPK7, ROCO2 | |
Human | |
Mammalian |